For the Quarter Ending March 2026
Dimethylacetamide Prices in North America
- In United States, the Dimethylacetamide Price Index rose quarter-over-quarter in Q1 2026, driven by escalating feedstock costs.
- The Dimethylacetamide Production Cost Trend increased significantly in March 2026 as the Producer Price Index rose 4.0%.
- The Dimethylacetamide Demand Outlook faced slight headwinds in March 2026 as the Consumer Price Index reached 3.3%.
- Industrial production grew 0.7% in March 2026, supporting the Dimethylacetamide Price Index amid recovering chemical intermediates activity.
- Retail sales grew 4.0% and consumer confidence hit 91.8 in March 2026, sustaining downstream Dimethylacetamide consumption levels.
- The Manufacturing Index expanded and unemployment remained at 4.3% in March 2026, stabilizing the broader Dimethylacetamide market.
- Feedstock methanol and natural gas costs spiked in March 2026 due to severe Gulf Coast storm outages.
- Domestic methanol supply tightened and export demand surged in March 2026, elevating the overall Dimethylacetamide Price Forecast.
Why did the price of Dimethylacetamide change in March 2026 in North America?
- Feedstock methanol costs spiked in March 2026 following severe Gulf Coast storm outages and shutdowns.
- The Producer Price Index rose 4.0% in March 2026, directly increasing Dimethylacetamide production and expenses.
- Strong export demand for methanol surged in March 2026, intensifying regional scarcity and cost pressures.
Dimethylacetamide Prices in APAC
- In China, the Dimethylacetamide Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- The Producer Price Index rose 0.5% in March 2026, pushing the Dimethylacetamide Production Cost Trend upward.
- Consumer Price Index grew 1.0% in March 2026, providing baseline support for the Dimethylacetamide Demand Outlook.
- Industrial production increased 5.7% in March 2026, boosting Dimethylacetamide consumption in bulk industrial solvent applications.
- The Manufacturing Index expanded in March 2026, reflecting increased factory operating rates and industrial activity.
- Retail sales grew 1.7% and unemployment reached 5.4% in March 2026, dampening downstream apparel market demand.
- The consumer confidence index hit 91.6 in February 2026, reducing spending on consumer electronics and textiles.
- Elastane fiber demand weakened in Q1 2026, negatively impacting the Dimethylacetamide Demand Outlook for textile applications.
- The Dimethylacetamide Price Forecast trended higher in March 2026 as methanol and acetic acid feedstock costs spiked.
Why did the price of Dimethylacetamide change in March 2026 in APAC?
- Methanol feedstock costs surged in March 2026 due to severe Middle East import supply disruptions.
- Acetic acid feedstock inventories tightened significantly in March 2026, directly elevating Dimethylacetamide upstream production expenses.
- Crude oil prices surged in March 2026 amid regional tensions, elevating broader petrochemical feedstock costs.
Dimethylacetamide Prices in Europe
- In Germany, the Dimethylacetamide Price Index rose quarter-over-quarter in Q1 2026, driven by surging feedstock costs.
- Consumer inflation reached 2.7% in March 2026, while producer prices declined by 0.2% during the same period.
- Industrial production remained flat at 0.0% in February 2026, alongside a modest 0.7% retail sales increase.
- The unemployment rate stood at 4.2% in February 2026, while consumer confidence dropped to -24.7 in March 2026.
- The Manufacturing Index expanded in March 2026, which supported a stronger Dimethylacetamide Demand Outlook across European markets.
- The Dimethylacetamide Production Cost Trend increased as European spot prices for methanol surged during February and March 2026.
- Middle East chemical export flows to Europe halted in Q1 2026, which tightened regional feedstock availability significantly.
- The Dimethylacetamide Price Forecast remained elevated as buyers actively built inventories amid supply fears in March 2026.
Why did the price of Dimethylacetamide change in March 2026 in Europe?
- European spot prices for methanol, a key feedstock, surged significantly during February and March 2026.
- Middle East chemical export flows to Europe halted entirely, tightening regional supply in Q1 2026.
- European chemical buyers actively secured contract volumes to build inventory buffers during March 2026.
For the Quarter Ending December 2025
Dimethylacetamide Prices in North America
- In United States, the Dimethylacetamide Price Index rose quarter-over-quarter in Q4 2025, driven by increasing production costs and robust industrial activity.
- Dimethylacetamide production costs increased in Q4 2025, influenced by a 3.0% year-over-year rise in PPI in November 2025.
- Methanol supplies were impacted by outages in Q4 2025, contributing to rising feedstock costs in October 2025.
- General inflation, with CPI up 2.7% year-over-year in December 2025, also elevated Dimethylacetamide manufacturing expenses.
- Dimethylacetamide demand strengthened in Q4 2025, supported by a 2.0% year-over-year increase in industrial production in December 2025.
- Robust consumer spending, indicated by a 3.3% year-over-year rise in retail sales in November 2025, indirectly boosted Dimethylacetamide demand.
- A 4.4% unemployment rate in December 2025 supported consumer spending, indirectly driving Dimethylacetamide demand.
- Global trade flows for chemicals, including Dimethylacetamide, remained soft in Q4 2025 due to higher US tariffs taking effect.
Why did the price of Dimethylacetamide change in December 2025 in North America?
- Rising production costs, with CPI up 2.7% year-over-year in December 2025, elevated Dimethylacetamide prices.
- Increased industrial production, up 2.0% year-over-year in December 2025, boosted Dimethylacetamide demand.
- Methanol supply disruptions in Q4 2025 contributed to higher feedstock costs for Dimethylacetamide.
Dimethylacetamide Prices in APAC
- In China, Dimethylacetamide Price Index fluctuated in Q4 2025, influenced by mixed macroeconomic signals.
- Dimethylacetamide production costs rose in Q4 2025 from volatile methanol and tight ammonia supply in early December.
- Dimethylacetamide demand remained robust in Q4 2025, driven by industrialization, textiles, and pharmaceuticals.
- China's industrial production grew 5.2% in December 2025, and the Manufacturing Index expanded, supporting Dimethylacetamide demand.
- Weak consumer demand (0.8% CPI, 0.9% retail sales growth in December 2025) tempered market sentiment and pricing power.
- Ammonia inventory levels increased in late December 2025, contributing to market weakening despite earlier supply tightness.
- Acetic acid prices surged in Asian markets in late Q4 2025 due to reduced plant operating rates.
- Unemployment at 5.1% in December 2025 and cooled consumer confidence in Q4 2025 indicated cautious spending.
Why did the price of Dimethylacetamide change in December 2025 in APAC?
- Weak consumer demand, with 0.8% CPI and 0.9% retail sales growth in December 2025, limited market strength.
- Production costs were pressured by tight ammonia supply in early December and volatile methanol prices.
- Robust industrial production, growing 5.2% in December 2025, supported Dimethylacetamide demand from key sectors.
Dimethylacetamide Prices in Europe
- In Germany, the Dimethylacetamide Price Index fell in Q4 2025, influenced by weak industrial pricing power in December 2025.
- Production costs rose; ammonia expenses increased in October 2025, with methanol prices volatile in December 2025.
- Demand was mixed; industrial production grew 0.8% in October 2025, but Manufacturing Index contracted in December 2025.
- Consumer confidence was significantly negative at -17.5 in December 2025, impacting Dimethylacetamide demand.
- Overall chemical production in Germany declined throughout 2025, tightening Dimethylacetamide supply.
- Western European domestic methanol supply remained lower in Q4 2025, necessitating increased imports.
- Automotive sector vehicle deliveries strengthened in Q4 2025, and pharmaceutical production grew throughout 2025.
- European natural gas markets experienced intense volatility in Q4 2025, impacting Dimethylacetamide feedstock costs.
Why did the price of Dimethylacetamide change in December 2025 in Europe?
- Weak industrial pricing power, indicated by a -2.5% PPI in December 2025, pressured Dimethylacetamide prices.
- Contracting Manufacturing Index in December 2025 signaled reduced demand from key industrial sectors.
- Volatile methanol prices in December 2025 and rising ammonia costs in October 2025 impacted production expenses.
For the Quarter Ending September 2025
Dimethylacetamide Prices in North America
- In the United States, the Dimethylacetamide Price Index slipped quarter over quarter, reflecting muted downstream activity.
- Dimethylacetamide Spot Price weakened as coatings and polymer demand remained subdued, with pharma uptake steady but insufficient to offset declines.
- Dimethylacetamide Price Forecast points to continued softness, driven by comfortable inventories and steady operating rates.
- Dimethylacetamide Production Cost Trend remained flat, supported by stable feedstock and energy inputs.
- Dimethylacetamide Demand Outlook stayed cautious, with limited restocking and thin spot inquiries across industrial solvents.
- The Price Index reflected balanced supply chains, no feedstock disruptions, and steady logistics.
- Regional freight stability kept distribution costs contained, but demand weakness capped upside momentum.
Why did the price of Dimethylacetamide change in September 2025 in North America?
- Prices decreased as downstream demand remained weak, inventories were comfortable, and no bullish triggers emerged.
- Stable production flows and absence of feedstock constraints tilted the balance in favor of buyers.
- Spot activity was muted, reinforcing downward pressure despite steady pharma consumption.
Dimethylacetamide Prices in APAC
- In China, the Dimethylacetamide Price Index rose by 0% quarter-over-quarter, reflecting stable market conditions domestically.
- The average Dimethylacetamide price for the quarter was approximately USD 800.67/MT per domestic trading reports.
- Dimethylacetamide Spot Price firmed notably as domestic pharmaceutical demand and industrial solvent uptake strengthened volumes.
- Dimethylacetamide Price Forecast shows modest upside risk linked to sustained downstream purchasing and moderate operating rates.
- Dimethylacetamide Production Cost Trend remained contained despite lower freight costs, with feedstock and energy pressures mixed.
- Dimethylacetamide Demand Outlook improved driven by renewed API production and increased chemical industry consumption domestically.
- Dimethylacetamide Price Index stability reflected steady inventories, balanced export demand, and selective producer supply discipline.
- Regional logistical relief reduced distribution costs but failed to offset tight domestic supply and order-driven output.
Why did the price of Dimethylacetamide change in September 2025 in APAC?
- Renewed domestic pharmaceutical demand increased consumption, tightening supplies and supporting higher spot pricing across regions.
- Moderate operating rates at plants constrained incremental supply while freight cost declines provided limited downward pressure.
- Selective producer output adjustments and firm downstream buying maintained price stability despite softer global logistics costs.
Dimethylacetamide Prices in Europe
- In Germany, the Dimethylacetamide Price Index fell quarter over quarter, reflecting subdued industrial activity.
- Dimethylacetamide Spot Price softened as textile and coatings demand underperformed, while pharma orders steadied volumes.
- Dimethylacetamide Price Forecast suggests range bound movement, with limited upside risk.
- Dimethylacetamide Production Cost Trend remained contained amid stable energy tariffs and feedstock availability.
- Dimethylacetamide Demand Outlook was neutral, with patchy sectoral performance.
- Price Index stability reflected balanced imports, steady domestic output, and no major supply alerts.
- Logistics ran smoothly, reducing distribution costs but failing to offset weak demand.
Why did the price of Dimethylacetamide change in September 2025 in Europe?
- Prices decreased marginally as converters delayed purchases and maintained thin safety stocks.
- Pharma demand steadied but was insufficient to counter weaker industrial solvent consumption.
- Smooth supply chains and balanced inventories reinforced the downward bias.
For the Quarter Ending March 2025
North America
The Dimethylacetamide (DMAC) market showed slightly declining trend during the first quarter, driven by subdued activity in its key downstream sectors—pharmaceuticals and construction. Despite some resilience shown by the pharmaceutical sector, the overall demand remained insufficient to support price growth. While pharma exports remained steady, domestic pharmaceutical consumption plateaued, and market participants adopted on-demand procurement strategies instead of bulk buying, contributing to reduced offtake volumes. This restrained buying behavior kept pressure on DMAC prices, as manufacturers refrained from raising quotations due to sufficient inventory levels and low urgency for replenishment.
Simultaneously, the construction sector in North America remained weak, weighed down by economic uncertainty, higher interest rates, and lower housing starts. This decline in new construction activity directly impacted demand for DMAC -based construction applications, including insulation and coatings. Combined with stable supply conditions and minimal logistic cost fluctuations, the limited momentum from both sectors failed to generate upward pricing pressure.
As a result, cautious downstream demand and steady supply dynamics led to a modest yet notable price decline in the region.
EUROPE
In the first quarter of 2025, the DMAC market showed mixed trend as Europe's construction sector exhibited varied trends. While there are signs of a gradual recovery driven by demand for modernized infrastructure and sustainable buildings, certain segments, such as residential construction in Germany, continue to face challenges. Building permits for apartments in Germany declined by 2.3% in February compared to the same month the previous year, indicating ongoing struggles in the property sector.
The pharmaceutical industry in Europe is navigating uncertainties due to potential U.S. tariffs on imported medicines. Major pharmaceutical companies have appealed to the European Commission for support to maintain their presence in the EU, highlighting economic disadvantages compared to the U.S. In response to tariff threats, Irish pharmaceutical exports to the U.S. surged by over 450% year-on-year in February, reaching €10.5 billion, as companies increased shipments to mitigate potential trade barriers.
These developments reflect a complex landscape for Europe's construction and pharmaceutical sectors in early 2025, characterized by both opportunities for growth and challenges posed by external economic factors.
APAC
The APAC Dimethylacetamide market in Q1 2025 displayed subdued price fluctuations, indicative of balanced supply chain dynamics and restrained procurement by manufacturers. Demand remained stable, bolstered by consistent consumption in downstream construction and pharmaceutical sectors, despite reduced new order volumes. Freight cost reductions and efficient port operations supported steady trading activities, although sporadic logistical disruptions dampened market momentum. Adequate inventory levels further sustained neutral market sentiment throughout the quarter.
In China, Dimethylacetamide prices fell by 7.87% from Q4 2024 to Q1 2025, averaging USD 804/MT on an FOB-Nanjing basis. Prices demonstrated a flat intra-quarter trend, reflecting stable supply chains and sufficient inventories. Demand from construction remained consistent, while a recovering pharmaceutical sector provided additional support. However, bearish market sentiment prevailed due to limited new order inflows.
Looking ahead, the near-term outlook for the market is cautiously stable, with modest upward potential tied to fluctuations in feedstock costs and anticipated improvements in sectoral demand, particularly from pharmaceuticals and construction.
